ClassID:

20020

A61K9/0019 - page 17 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Recent Application in this class:
#4801
20220177536
2022-06-09

T-cell modulatory multimeric polypeptides and methods of use thereof

#4802
20220177494
2022-06-09

pH-RESPONSIVE SILICA METAL ORGANIC FRAMEWORK NANOPARTICLES FOR DELIVERY OF BIOACTIVE MOLECULES

#4803
20220177470
2022-06-09

Sulfoximine glycosidase inhibitors

#4804
20220177427
2022-06-09

Tryptamine Prodrugs

#4805
20220175965
2022-06-09

AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)

#4806
20220175964
2022-06-09

DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS

#4807
20220175952
2022-06-09

TREATING MYELOMAS

#4808
20220175950
2022-06-09

Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof

#4809
20220175924
2022-06-09

LIQUID PHARMACEUTICAL COMPOSITION

#4810
20220175923
2022-06-09

FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES

#4811
20220175887
2022-06-09

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS

#4812
20220175883
2022-06-09

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

#4813
20220175880
2022-06-09

Chloride salt of TAT-NR2B9C

#4814
20220175874
2022-06-09

POLYMERIC NANOPARTICLES AND A PROCESS OF PREPARATION THEREOF

#4815
20220175849
2022-06-09

COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS

#4816
20220175838
2022-06-09

Tumoricidal and antimicrobial compositions and methods

#4817
20220175823
2022-06-09

POLYMER AGENTS FOR CARDIOPULMONARY RESUSCITATION

#4818
20220175785
2022-06-09

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

#4819
20220175759
2022-06-09

COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING SMALL CELL LUNG CANCER

#4820
20220175753
2022-06-09

TREATING OF SIDE-EFFECTS RESULTING FROM CHEMODENERVATION

#4821
20220175747
2022-06-09

Opioid receptor ligands and methods of using and making same

#4822
20220175718
2022-06-09

TRANSDERMAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF CANCER

#4823
20220175715
2022-06-09

CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF

#4824
20220175706
2022-06-09

Calcium lactate compositions and methods of use

#4825
20220175688
2022-06-09

POLYMERIC NANOPARTICLES

#4826
20220175665
2022-06-09

Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity

#4827
20220175664
2022-06-09

Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity

#4828
20220175663
2022-06-09

STABLE LIQUID ANTIBODY FORMULATION

#4829
20220175661
2022-06-09

SYNERGIST THERAPY FOR ENHANCED DRUG DELIVERY: MAGNETIC FIELD FACILITATED NANOPARTICLE MICROPORATION

#4830
20220170015
2022-06-02

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

#4831
20220169804
2022-06-02

METHOD FOR DEACETYLATION OF BIOPOLYMERS

#4832
20220169638
2022-06-02

6-pyrimidin-isoindole derivative as ERK1/2 inhibitor

#4833
20220169612
2022-06-02

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

#4834
20220168497
2022-06-02

Methods for ensuring resuspension of paliperidone palmitate formulations

#4835
20220168484
2022-06-02

Implantable pump for direct sodium removal therapy having on-board analyte sensor

#4836
20220168449
2022-06-02

COMPOSITIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTICS

#4837
20220168395
2022-06-02

COMBINED PHARMACEUTICAL COMPOSITION

#4838
20220168391
2022-06-02

USE OF EPIDERMAL GROWTH FACTOR IN DIABETIC FOOT ULCER TREATMENT

#4839
20220168381
2022-06-02

Formulations containing a somatostatin receptor agonist

#4840
20220168362
2022-06-02

BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID

#4841
20220168306
2022-06-02

Dosing regimens associated with extended release paliperidone injectable formulations

#4842
20220168305
2022-06-02

Dosing regimens associated with extended release paliperidone injectable formulations

#4843
20220168283
2022-06-02

Treatment of progressive neurodegenerative disease with ibudilast

#4844
20220168282
2022-06-02

Inhibition of COVID-19 virus

#4845
20220168266
2022-06-02

Cannabidiol preparations and its uses

#4846
20220168262
2022-06-02

AMPHIPHILIC PLATINUM (IV) PRODRUG AND CANCER TREATMENT PROCESS

#4847
20220168232
2022-06-02

CAPSULE COMPRISING INSULIN-SECRETING CELLS FOR TREATING DIABETES

#4848
20220168223
2022-06-02

Liposomes encapsulating adenosine

#4849
20220168222
2022-06-02

LIPID NANOPARTICLES

#4850
20220168215
2022-06-02

USE OF COMPOSITION FOR REDUCING OR PREVENTING CELL AGING OR REPAIRING CELL WITH DAMAGED MITOCHONDRIA, METHOD OF PREPARING COMPOSITION FOR CELL REPAIRING, CELL REPAIRING METHOD AND METHOD OF SUPPLYING MITOCHONDRIA INTO CELL

#4851
20220162326
2022-05-26

Anti-IL36R antibodies

#4852
20220162307
2022-05-26

METHODS AND COMPOSITIONS FOR TREATING ALLERGIC OCULAR DISEASES

#4853
20220162279
2022-05-26

COMBINATION IMMUNOTHERAPY

#4854
20220160899
2022-05-26

COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA

#4855
20220160889
2022-05-26

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

#4856
20220160878
2022-05-26

Topiramate compositions and methods of making and using the same

#4857
20220160875
2022-05-26

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#4858
20220160845
2022-05-26

Therapeutic agent for disc herniation

#4859
20220160844
2022-05-26

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#4860
20220160834
2022-05-26

Treatment Of Intervertebral Disc Degeneration

#4861
20220160829
2022-05-26

USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE

#4862
20220160817
2022-05-26

Pharmaceutical composition with improved stability

#4863
20220160816
2022-05-26

ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO

#4864
20220160768
2022-05-26

Tumoricidal and antimicrobial compositions and methods

#4865
20220160754
2022-05-26

Derivatized chitosan polymers and methods of treating vascular disorders

#4866
20220160722
2022-05-26

Stable antiemetic emulsions

#4867
20220160718
2022-05-26

COMPOSITIONS AND METHODS OF TREATING CANCER

#4868
20220160701
2022-05-26

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING BCN057 OR BCN512

#4869
20220160694
2022-05-26

PLASMA KALLIKREIN INHIBITORS AND METHODS OF USE THEREOF IN OCULAR DISORDERS

#4870
20220160679
2022-05-26

COMPOSITIONS AND METHODS FOR CANCER THERAPY

#4871
20220160677
2022-05-26

TUMESCENT INFILTRATION DRUG DELIVERY OF CANNABINOIDS

#4872
20220160666
2022-05-26

COMPOSITIONS FOR USE IN SURGERY

#4873
20220160644
2022-05-26

Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery

#4874
20220160621
2022-05-26

METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE PREPARATION

#4875
20220153867
2022-05-19

MUC16 specific chimeric antigen receptors and uses thereof

#4876
20220153866
2022-05-19

MUC16 specific chimeric antigen receptors and uses thereof

#4877
20220153857
2022-05-19

ANTI-CD40 ANTIBODIES

#4878
20220152201
2022-05-19

Sensitizing cells to proton radiation

#4879
20220152199
2022-05-19

Engineered chimeric fusion protein compositions and methods of use thereof

#4880
20220152170
2022-05-19

Peptide vaccine formulations and use thereof for inducing an immune response

#4881
20220152160
2022-05-19

DOSING REGIMEN

#4882
20220152158
2022-05-19

Irisin improves placental function during pregnancy

#4883
20220152151
2022-05-19

ACELLULAR INTRAVENOUS INFUSION INCLUDING MESENCHYMAL STEM CELL GROWTH FACTORS AND EXOSOMES

#4884
20220152139
2022-05-19

PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF

#4885
20220152113
2022-05-19

METHODS FOR TREATING NON-CANCEROUS DISORDERS USING HEMATOPOIETIC CELLS

#4886
20220152094
2022-05-19

STABILIZED AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF NEUROLOGICAL, MUSCULAR AND INFERTILITY DISEASES OR CONDITIONS

#4887
20220152091
2022-05-19

OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY

#4888
20220152084
2022-05-19

Particle-mediated delivery of biologics

#4889
20220152079
2022-05-19

Methods For The Treatment Of APOC3-Related Diseases And Disorders

#4890
20220152076
2022-05-19

Injectable bifunctional hydrogel with antibacterial activity as well as the preparative method and the use thereof

#4891
20220152070
2022-05-19

PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE

#4892
20220152049
2022-05-19

METHODS OF TESTOSTERONE THERAPY

#4893
20220152045
2022-05-19

DOSING REGIMEN OF SEDATIVE

#4894
20220152029
2022-05-19

Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding antagonist for treating lung cancer

#4895
20220152021
2022-05-19

Aripiprazole dosing strategy

#4896
20220152015
2022-05-19

NEDOCROMIL SODIUM TO PREVENT, LIMIT ONSET, AND /OR TREAT PANCREATIC CANCER

#4897
20220152003
2022-05-19

Formulations of hydroxypyridonate actinide/lanthanide decorporation agents

#4898
20220151994
2022-05-19

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA USING 6,8-BISBENZYLTHIO-OCTANOIC ACID

#4899
20220151990
2022-05-19

FORMULATIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE

#4900
20220151963
2022-05-19

PARENTERAL DELIVERY OF AVIZAFONE

#4901
20220151956
2022-05-19

More potent and less toxic formulations of epinephrine and methods of medical use

#4902
20220151946
2022-05-19

Process for the preparation of drug loaded microparticles

#4903
20220151923
2022-05-19

STABLE LIQUID COMPOSITIONS OF PEMETREXED

#4904
20220144990
2022-05-12

Polymer particles

#4905
20220144922
2022-05-12

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

#4906
20220144918
2022-05-12

Long-acting VEGF inhibitors for intraocular neovascularization

#4907
20220143228
2022-05-12

HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS

#4908
20220143197
2022-05-12

siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer

#4909
20220143187
2022-05-12

PRESERVED FORMULATIONS

#4910
20220143158
2022-05-12

DUODENAL ADMINISTRATION OF BOTULINUM TOXIN

#4911
20220143157
2022-05-12

NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR

#4912
20220143152
2022-05-12

USE OF PEPTIDE DERIVED FROM H-REV107

#4913
20220143132
2022-05-12

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

#4914
20220143127
2022-05-12

Method for treating psoriasis

#4915
20220143071
2022-05-12

ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING

#4916
20220143057
2022-05-12

Water dissolvable macrocyclic lactone cyclodextrin complexes

#4917
20220143048
2022-05-12

Prodrug salts

#4918
20220143044
2022-05-12

FULVESTRANT FORMULATIONS

#4919
20220143041
2022-05-12

COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS

#4920
20220143027
2022-05-12

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

#4921
20220143009
2022-05-12

Combination of antibody-drug conjugate and immune checkpoint inhibitor

#4922
20220143004
2022-05-12

USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS

#4923
20220142998
2022-05-12

Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene

#4924
20220142992
2022-05-12

Formulations, methods, kits, and dosage forms

#4925
20220142954
2022-05-12

METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING

#4926
20220142934
2022-05-12

COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES

#4927
20220142915
2022-05-12

Dental Local Anesthetic Solution

#4928
20220142914
2022-05-12

SUSPENSION FORMULATIONS OF HIGH LOAD DISPERSIONS

#4929
20220142866
2022-05-12

Sterile aztreonam package

#4930
20220136011
2022-05-05

TELOMERASE-CONTAINING EXOSOMES FOR TREATMENT OF DISEASES ASSOCIATED WITH AGING AND AGE-RELATED ORGAN DYSFUNCTION

#4931
20220135696
2022-05-05

USE OF ISATUXIMAB FOR THE TREATMENT OF MULTIPLE MYELOMA

#4932
20220135683
2022-05-05

Anti-PD1 and anti-CTLA4 antibodies

#4933
20220135638
2022-05-05

GIP receptor agonist peptide compounds and uses thereof

#4934
20220135532
2022-05-05

Crystalline PPARδ agonist

#4935
20220133890
2022-05-05

PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE

#4936
20220133888
2022-05-05

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER

#4937
20220133883
2022-05-05

METHOD FOR ELICITING AN IMMUNE RESPONSE TO AN IMMUNOGEN

#4938
20220133881
2022-05-05

Herpesvirus compositions and related methods

#4939
20220133863
2022-05-05

TREATMENT OF SANFILIPPO SYNDROME TYPE B

#4940
20220133862
2022-05-05

Methods and compositions for CNS delivery of heparan N-sulfatase

#4941
20220133861
2022-05-05

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT EDEMA

#4942
20220133852
2022-05-05

Reconstituted high density lipoprotein formulation and production method thereof

#4943
20220133838
2022-05-05

Vasopressin formulations for use in treatment of hypotension

#4944
20220133825
2022-05-05

ONCOLYTIC VIRUSES TARGETING STAT3

#4945
20220133824
2022-05-05

ONCOLYTIC VIRUSES TARGETING STAT3

#4946
20220133800
2022-05-05

TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING

#4947
20220133799
2022-05-05

Early apoptotic cells for use treating sepsis

#4948
20220133775
2022-05-05

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

#4949
20220133769
2022-05-05

Methods for Treatment of Alport Syndrome

#4950
20220133754
2022-05-05

METHOD FOR HYDRATING LYOPHILIZED CYCLOPHOSPHAMIDE COMPOSITION AND PRODUCT THEREOF

#4951
20220133704
2022-05-05

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD

#4952
20220133697
2022-05-05

INJECTABLE FORMULATIONS

#4953
20220133696
2022-05-05

Ifetroban Treatment for Systemic Sclerosis

#4954
20220133687
2022-05-05

METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS

#4955
20220133684
2022-05-05

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

#4956
20220133652
2022-05-05

A FORMULATION FOR IMPROVING SEIZURE CONTROL

#4957
20220127608
2022-04-28

P-ethoxy nucleic acids for STAT3 inhibition

#4958
20220127607
2022-04-28

METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SITE IN EXON 5 OF THE DMD GENE

#4959
20220127572
2022-04-28

METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION

#4960
20220127348
2022-04-28

METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR

#4961
20220127271
2022-04-28

Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation method, and use

#4962
20220125992
2022-04-28

Conformal coating of cells for immunoisolation

#4963
20220125929
2022-04-28

PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR

#4964
20220125896
2022-04-28

Compositions and methods for treatment of homocystinuria

#4965
20220125889
2022-04-28

COMPOSITION COMPRISING ALBUMIN-COUPLED SLIT3 LRRD2 FOR PREVENTION OR TREATMENT OF MUSCLE DISEASE

#4966
20220125888
2022-04-28

Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same

#4967
20220125887
2022-04-28

USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK

#4968
20220125848
2022-04-28

METHOD FOR TREATING OSTEOARTHRITIS WITH A COMBINATION OF MESENCHYMAL STEM CELL EXOSOMES, SYNOVIAL MESENCYMAL STEM CELLS, AND SCAFFOLDS

#4969
20220125831
2022-04-28

REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD

#4970
20220125825
2022-04-28

S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS

#4971
20220125823
2022-04-28

EXTRAHEPATIC DELIVERY

#4972
20220125813
2022-04-28

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#4973
20220125811
2022-04-28

INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME

#4974
20220125808
2022-04-28

LIPID COMPOSITIONS WITH HIGH DHA CONTENT

#4975
20220125798
2022-04-28

Ready-to-use injectable formulations

#4976
20220125776
2022-04-28

Treatment of acute myeloid leukemia (AML) with venetoclax failure

#4977
20220125750
2022-04-28

Methods of treating injuries or conditions related to CNS edema

#4978
20220125749
2022-04-28

TRIPLE COMBINATION FORMULATION FOR TREATMENT OF CHRONIC PAIN

#4979
20220125735
2022-04-28

MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION

#4980
20220125718
2022-04-28

STABILIZED Fc FUSION PROTEIN SOLUTIONS

#4981
20220125713
2022-04-28

Hematocrit Modulation Through Needle Assisted Jet Injection of Testosterone

#4982
20220120542
2022-04-21

BALLISTIC DELIVERY METHOD AND SYSTEM FOR INJECTABLE FORMULATIONS

#4983
20220119813
2022-04-21

EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION

#4984
20220119514
2022-04-21

METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR

#4985
20220118188
2022-04-21

Method of injecting octreotide acetate into the body

#4986
20220118122
2022-04-21

STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS

#4987
20220118111
2022-04-21

Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12

#4988
20220118110
2022-04-21

Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12

#4989
20220118092
2022-04-21

Process for preparing an immunoglobulin preparation

#4990
20220118082
2022-04-21

Compositions and methods for generating an immune response to hepatitis B virus

#4991
20220118053
2022-04-21

Dry Pharmaceutical Formulations of CNP Conjugates

#4992
20220118044
2022-04-21

Injectable garlic formulation and a method of using the injectable garlic formulation

#4993
20220117994
2022-04-21

METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS

#4994
20220117988
2022-04-21

COMPOSITIONS AND METHODS FOR TREATING AN INFECTION

#4995
20220117946
2022-04-21

HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE

#4996
20220117940
2022-04-21

COMPOSITION FOR INCREASING PREGNANCY RATE OF RUMINANTS AND PREPARATION METHOD AND APPLICATION THEREOF

#4997
20220117931
2022-04-21

ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS

#4998
20220117924
2022-04-21

Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods

#4999
20220117913
2022-04-21

DEZOCINE DERIVATIVE AND MEDICAL USE THEREOF

#5000
20220117892
2022-04-21

Composition of docetaxel liposomal injection with high drug loading

#5001
20220117883
2022-04-21

TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE

#5002
20220112466
2022-04-14

Stromal stem cells

#5003
20220112276
2022-04-14

BIOSYNTHETIC MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATION

#5004
20220112268
2022-04-14

Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use

#5005
20220112238
2022-04-14

MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS

#5006
20220111114
2022-04-14

EMBOLIC MICROSPHERES

#5007
20220111076
2022-04-14

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

#5008
20220111075
2022-04-14

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

#5009
20220111074
2022-04-14

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

#5010
20220111072
2022-04-14

Lipid nanoparticle compositions and methods for mRNA delivery

#5011
20220111071
2022-04-14

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

#5012
20220111070
2022-04-14

Lipid nanoparticle compositions and methods for MRNA delivery

#5013
20220111069
2022-04-14

Immunoswitch nanoparticles for reprogrammed T cell responses

#5014
20220111067
2022-04-14

MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF

#5015
20220111048
2022-04-14

ANTIBODY FORMULATIONS

#5016
20220111046
2022-04-14

CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY

#5017
20220111038
2022-04-14

COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, AND METHODS OF USING THE SAME

#5018
20220111012
2022-04-14

METHODS OF PROMOTING REMYELINATION

#5019
20220111010
2022-04-14

Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions

#5020
20220110999
2022-04-14

METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

#5021
20220110966
2022-04-14

POLYNUCLEOTIDES ENCODING VERY LONG-CHAIN ACYL-COA DEHYDROGENASE FOR THE TREATMENT OF VERY LONG-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY

#5022
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

#5023
20220110895
2022-04-14

Beta-hydroxybutyrate mixed salt compositions and methods of use

#5024
20220110893
2022-04-14

Method of treating cancer using selective estrogen receptor modulators

#5025
20220110892
2022-04-14

Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

#5026
20220110891
2022-04-14

Epinephrine compositions and containers

#5027
20220110861
2022-04-14

Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors

#5028
20220105207
2022-04-07

Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer

#5029
20220105201
2022-04-07

Lipid nanoparticle compositions and methods for mRNA delivery

#5030
20220105191
2022-04-07

BIOORTHOGONAL COMPOSITIONS

#5031
20220105189
2022-04-07

POLYETHYLENE GLYCOL CONJUGATED DRUG AND ITS PREPARATION METHOD AND USE

#5032
20220105156
2022-04-07

METHODS OF TREATMENT FOR KIDNEY DISEASE

#5033
20220105154
2022-04-07

Hard tissue therapeutics

#5034
20220105133
2022-04-07

TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY

#5035
20220105132
2022-04-07

Method for Producing an Exosome Containing Agent for Metastasis Suppression

#5036
20220105116
2022-04-07

Method of reconstituting liposomal annamycin

#5037
20220105114
2022-04-07

METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS

#5038
20220105066
2022-04-07

Antidotes to Cyanide Poisoning

#5039
20220105038
2022-04-07

Microparticles comprising PCL and uses thereof

#5040
20220105028
2022-04-07

METHOD FOR IMPROVING STORAGE STABILITY

#5041
20220105027
2022-04-07

Medroxyprogesterone acetate injectable compositions and methods of use

#5042
20220104759
2022-04-07

Reversal of General Anesthesia by Administration of Methylphenidate, Amphetamine, Modafinil, Amantadine, and/or Caffeine

#5043
20220098315
2022-03-31

ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF HIDRADENITIS

#5044
20220098287
2022-03-31

TREATING REFRACTORY MIGRAINE

#5045
20220098260
2022-03-31

BH4 Stabilized Peptides And Uses Thereof

#5046
20220098239
2022-03-31

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

#5047
20220098182
2022-03-31

Compounds active towards nuclear receptors

#5048
20220098179
2022-03-31

Piperazine derivatives, pharmaceutical compositions and methods of use thereof

#5049
20220096659
2022-03-31

METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS

#5050
20220096657
2022-03-31

COMPOSITIONS FOR THE TREATMENT OF DISEASE

#5051
20220096639
2022-03-31

THERMOREVERSIBLE COMPOSITIONS FOR ADMINISTRATION OF THERAPEUTIC AGENTS

#5052
20220096638
2022-03-31

Injectable preparation

#5053
20220096615
2022-03-31

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

#5054
20220096610
2022-03-31

Methods of treatment for cervical dystonia

#5055
20220096607
2022-03-31

SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF

#5056
20220096603
2022-03-31

Insulin formulations and uses in infusion devices

#5057
20220096564
2022-03-31

METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS

#5058
20220096562
2022-03-31

OSTEOBLAST CELL-MIXTURE, AND IMPLEMENTATIONS THEREOF

#5059
20220096560
2022-03-31

METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES

#5060
20220096558
2022-03-31

SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS

#5061
20220096557
2022-03-31

Method for treating osteoarthritis

#5062
20220096532
2022-03-31

Composition for treating joint disease and kit containing same

#5063
20220096508
2022-03-31

METHOD OF TREATMENT AND PHARMACEUTICAL DOSAGE FORM

#5064
20220096507
2022-03-31

Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO

#5065
20220096503
2022-03-31

COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF

#5066
20220096498
2022-03-31

INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION

#5067
20220096493
2022-03-31

Precipitation resistant small molecule drug formulations

#5068
20220096470
2022-03-31

PHARMACEUTICAL COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION OF LEVOSIMENDAN

#5069
20220096459
2022-03-31

RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS

#5070
20220096458
2022-03-31

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan

#5071
20220096447
2022-03-31

TREATMENT OF RESTENOSIS USING TEMSIROLIMUS

#5072
20220096435
2022-03-31

FABP4 as a therapeutic target in skin diseases

#5073
20220096423
2022-03-31

Treatment of Bladder Cancer by Local Administration of Taxane Particles

#5074
20220096414
2022-03-31

LEVOTHYROXINE LIQUID FORMULATIONS

#5075
20220096400
2022-03-31

METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS

#5076
20220096399
2022-03-31

METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10

#5077
20220096397
2022-03-31

Parenteral formulations

#5078
20220096392
2022-03-31

Edds chelated nanoceria with catalase-like activity

#5079
20220096383
2022-03-31

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

#5080
20220090128
2022-03-24

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

#5081
20220090087
2022-03-24

ANTISENSE OLIGONUCLEOTIDES TARGETING SCN2A RETAINED INTRONS

#5082
20220090076
2022-03-24

5-halouracil-modified microRNAs and their use in the treatment of cancer

#5083
20220090069
2022-03-24

OLIGONUCLEOTIDES FOR HTT-1A MODULATION

#5084
20220090019
2022-03-24

Stromal stem cells

#5085
20220090018
2022-03-24

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USED OF THE SAME IN IMMUNOTHERAPY

#5086
20220089753
2022-03-24

THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER

#5087
20220089710
2022-03-24

Method of Treating Signs and Symptoms of Osteoarthritis

#5088
20220089681
2022-03-24

Methods for modulating an immune response

#5089
20220089631
2022-03-24

COMPOUND COMPRISING MULTIVALENT SIALYLOLIGOSACCHARIDE RESIDUES, AND COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTION DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT

#5090
20220089583
2022-03-24

N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases

#5091
20220089547
2022-03-24

COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF NEURORETINAL DISEASES

#5092
20220088208
2022-03-24

PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS

#5093
20220088205
2022-03-24

Pharmaceutical preparation containing polyethylene gylcol loxenatide and preparation method thereof

#5094
20220088203
2022-03-24

Glycemic control using intrinsic factor bound to a vitamin Bconjugate of a glucagon-like peptide-1 receptor agonist

#5095
20220088198
2022-03-24

Targeting microbubbles

#5096
20220088194
2022-03-24

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

#5097
20220088157
2022-03-24

METHODS FOR TREATING HEADACHE

#5098
20220088132
2022-03-24

METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES

#5099
20220088115
2022-03-24

PHARMACEUTICAL COMPOSITION, COMPRISING INHIBITORY PEPTIDE AGAINST FAS SIGNALING, FOR PREVENTION OR TREATMENT OF OBESITY, FATTY LIVER, OR STEATOHEPATITIS

#5100
20220088083
2022-03-24

COMPOSITION FOR USE IN TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA